Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
3 |
Tacrine 10 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely tacrine 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely tacrine 30 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Tacrine 40 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Phenobarbital 16 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely phenytoin sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Trimethadione 300 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
imatinib 100 mg, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
indinavir 100 mg, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely ibuprofen 300 milligram and pseudoephedrine 45 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely ibuprofen 300 milligram and pseudoephedrine 45 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely magnesium malate 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
imatinibmesilat 50 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely trimethobenzamide hydrochloride 300 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely zonisamide 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely trandolapril 4 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
imatinib 400 mg, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely lithium carbonate 150 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Lithium carbonate 600 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Pregabalin 100 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely pregabalin 150 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Pregabalin 200 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Pregabalin 25 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely pregabalin 300 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Pregabalin 50 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely pregabalin 75 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Zinc 50 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Zonisamide 25 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely zonisamide 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely zinc 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely paricalcitol 4 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely paricalcitol 1 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely paricalcitol 2 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely tipranavir 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely sunitinib (as sunitinib malate) 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely lubiprostone 24 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Ibuprofen 200 mg and pseudoephedrine 30 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Ibuprofen 200 mg and pseudoephedrine 30 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely sunitinib (as sunitinib malate) 12.5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely lenalidomide 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Isotretinoin 30 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Pregabalin 225 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Sunitinib (as sunitinib malate) 50 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Lenalidomide 5 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
levotyroxinnatrium 150 mikrogram, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Saquinavir (as saquinavir mesilate) 200 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
levotyroxinnatrium 75 mikrogram, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Vorinostat 100 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
levotyroxinnatrium 50 mikrogram, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
levotyroxinnatrium 25 mikrogram, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
levotyroxinnatrium 100 mikrogram, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 125 microgram oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Phentermine resin 30 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely lisdexamfetamine dimesylate 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Lisdexamfetamine dimesylate 30 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Lisdexamfetamine dimesylate 70 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
topotekan 1 mg, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely quinine sulfate 324 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
topotekan 0,25 mg, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Temazepam 22.5 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely lisdexamfetamine dimesylate 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Lisdexamfetamine dimesylate 40 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely lisdexamfetamine dimesylate 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely sodium iodide (123-I) 7.4 megabecquerel/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely silodosin 8 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely silodosin 4 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely phentermine hydrochloride 15 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely temozolomide 140 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely temozolomide 180 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Vemurafenib 240 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely pomalidomide 1 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Pomalidomide 2 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely pomalidomide 3 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely pomalidomide 4 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Tafamidis meglumine 20 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Vismodegib 150 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely docusate sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
disopyramid 100 mg, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
disopyramid 150 mg, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely cinnarizine 75 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely gemfibrozil 300 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Fish derived omega 3 fatty acid 1 g oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Fenofibrate micronised 200 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Fenofibrate micronised 67 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 267 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
fluvastatin 20 mg, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
fluvastatin 40 mg, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Flurazepam (as flurazepam hydrochloride) 15 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Flurazepam (as flurazepam hydrochloride) 30 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 7.5 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 15 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |